Correlation Between Vera Therapeutics and Acurx Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Vera Therapeutics and Acurx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vera Therapeutics and Acurx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vera Therapeutics and Acurx Pharmaceuticals LLC, you can compare the effects of market volatilities on Vera Therapeutics and Acurx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vera Therapeutics with a short position of Acurx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vera Therapeutics and Acurx Pharmaceuticals.
Diversification Opportunities for Vera Therapeutics and Acurx Pharmaceuticals
-0.7 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Vera and Acurx is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Vera Therapeutics and Acurx Pharmaceuticals LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acurx Pharmaceuticals LLC and Vera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vera Therapeutics are associated (or correlated) with Acurx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acurx Pharmaceuticals LLC has no effect on the direction of Vera Therapeutics i.e., Vera Therapeutics and Acurx Pharmaceuticals go up and down completely randomly.
Pair Corralation between Vera Therapeutics and Acurx Pharmaceuticals
Given the investment horizon of 90 days Vera Therapeutics is expected to generate 0.75 times more return on investment than Acurx Pharmaceuticals. However, Vera Therapeutics is 1.34 times less risky than Acurx Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Acurx Pharmaceuticals LLC is currently generating about -0.18 per unit of risk. If you would invest 3,898 in Vera Therapeutics on September 6, 2024 and sell it today you would earn a total of 1,048 from holding Vera Therapeutics or generate 26.89% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Vera Therapeutics vs. Acurx Pharmaceuticals LLC
Performance |
Timeline |
Vera Therapeutics |
Acurx Pharmaceuticals LLC |
Vera Therapeutics and Acurx Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vera Therapeutics and Acurx Pharmaceuticals
The main advantage of trading using opposite Vera Therapeutics and Acurx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vera Therapeutics position performs unexpectedly, Acurx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acurx Pharmaceuticals will offset losses from the drop in Acurx Pharmaceuticals' long position.Vera Therapeutics vs. Candel Therapeutics | Vera Therapeutics vs. Cingulate Warrants | Vera Therapeutics vs. Unicycive Therapeutics | Vera Therapeutics vs. Cardio Diagnostics Holdings |
Acurx Pharmaceuticals vs. Aerovate Therapeutics | Acurx Pharmaceuticals vs. Adagene | Acurx Pharmaceuticals vs. Acrivon Therapeutics, Common | Acurx Pharmaceuticals vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |